GlobeNewswire Inc | May 27, 2021 04:30PM EDT

May 27, 2021

SAN DIEGO, May 27, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will present at the following upcoming virtual investor conferences in June:

Jefferies Virtual Healthcare Conference Date: Wednesday, June 2, 2021Time: 1:00 p.m. ET

JMP Securities Life Sciences Conference Date: Wednesday, June 16, 2021Time: 11:00 a.m. ET

BMO Biopharma Day: Spotlight on Rare Disease and Ophthalmology Date: Tuesday, June 22, 2021Time: 11:15 a.m. ET

Live webcasts will be available at https://ir.travere.com/events-presentations and archived replays will be accessible for up to 30 days.

About Travere Therapeutics

At Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope today and tomorrow. For more information, visit travere.com

Contact:Chris Cline, CFASenior Vice President, Investor Relations & Corporate Communications888-969-7879IR@travere.com